Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 623-628

  Lubecka Pietruszewska, Katarzyna ^a   Kaufman Szymczyk, Agnieszka ^a   Stefanska, Barbara ^b   Fabianowska Majewska, Krystyna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; DNA methylation; Epigenetic regulation of gene transcription; Folic acid

Indexed keywords

APC PROTEIN; DNA; DNA METHYLTRANSFERASE 1; FOLIC ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAR BETA2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, APC; GENES, TUMOR SUPPRESSOR; HUMANS; PTEN PHOSPHOHYDROLASE; RECEPTORS, RETINOIC ACID; RESTRICTION MAPPING;

EID: 84872285699     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.103     Document Type: Article

References (34)

1. Larsson S.C., Giovannucci E., Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006, 131:1271-1283.
2. Bazzano L.A., Reynolds K., Holder K.N., et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006, 296(22):2720-2726.
3. Mills J.L., Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res. A. Clin. Mol. Teratol. 2004, 70(11):844-845.
4. Bailey L.B., Gregory J.F. Folate metabolism and requirements. J. Nutr. 1999, 10:779-782.
5. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J. Nutr. Health Aging 2002, 6:39-42.
6. Stefanska B., Karlic H., Varga F., et al. Epigenetic mechanisms in anti-cancer actions of bioactive food components - the implications in cancer prevention. Br. J. Pharmacol. 2012, 167(2):279-297.
7. Hermann A., Gowher H., Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol. Life Sci. 2004, 61(19-20):2571-2587.
8. Szyf M., Pakneshan P., Rabbani S.A. DNA methylation and breast cancer. Biochem. Pharmacol. 2004, 68(6):1187-1197.
9. Kim Y.I. Does a high folate intake increase the risk of breast cancer?. Nutr. Rev. 2006, 64:468-475.
10. Choi S.W., Friso S., Keyes M.K., et al. Folate supplementation increases genomic DNA methylation in the liver of older rats. Br. J. Nutr. 2005, 93:31-35.
11. Choi S.W., Friso S. Interactions between folate and aging for carcinogenesis. Clin. Chem. Lab. Met. 2005, 43:1151-1157.
12. Kim Y.I. Role of folate in colon cancer development and progression. J. Nutr. 2003, 133:3731S-3739S.
13. Larsson S.C., Giovannucci E., Wolk A. Folate and risk of breast cancer: a meta-analysis. J. Natl. Cancer Inst. 2007, 99:64-76.
14. Wu K., Platz E.A., Willett W.C., et al. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am. J. Clin. Nutr. 2009, 90:1623-1631.
15. Rohan T.E., Jain M.G., Howe G.R., et al. Dietary folate consumption and breast cancer risk. J. Natl. Cancer Inst. 2000, 92:266-269.
16. Jaszewski R., Misra S., Tobi M., et al. Folic supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J. Gastroenterol. 2008, 14:4492-4498.
17. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007, 297:2351-2359.
18. Figueiredo J.C., Grau M.V., Haile R.W., et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J. Natl. Cancer Inst. 2009, 101:432-435.
19. Stolzenberg-Solomon R.Z., Chang S.C., Leitzmann M.F., et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Clin. Nutr. 2006, 83:895-904.
20. Stefanska B., Salame P., Bednarek A., et al. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of PTEN tumour suppressor gene in breast cancer cells. Br. J. Nutr. 2012, 107:781-790.
21. Stefanska B., Rudnicka K., Bednarek A., et al. Hypomethylation and induction of retinoic acid beta 2 (RAR beta 2) gene by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur. J. Pharmacol. 2010, 638:47-53.
22. Garcia J.M., Silva J., Pena C., et al. Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer 2004, 41:117-124.
23. Khan S., Kumagai T., Vora J., et al. PTEN promoter is methylated in proportion of invasive breast cancers. Int. J. Cancer. 2004, 112:407-410.
24. Widschwendter M., Berger J., Hermann M., et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J. Natl. Cancer Inst. 2000, 92:826-832.
25. Jin Z., Tamura G., Tsuchiya T., et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancer. Br. J. Cancer. 2001, 85:69-73.
26. Stefanska B., Huang J., Bhattacharyya B., et al. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res. 2011, 71(17):5891-5903.
27. Iwase H., Omoto Y., Iwata H., et al. DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers. Br. J. Cancer. 1999, 80:1982-1986.
28. Krawczyk B., Rudnicka K., Fabianowska-Majewska K. The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines. Nucleosides Nucleotides Nucleic Acids 2007, 26:1043-1046.
29. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:1-10.
30. Ly A., Lee H., Chen J., et al. Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring. Cancer Res. 2011, 71:988-997.
31. Ly A., Hoyt L., Crowell J., Kim Y-I. Folate and DNA methylation. Antioxid. Redox Signaling 2012, 17:302-326.
32. Kim Y-I. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13:511-519.
33. Berner C., Aumuller E., Gnauck A., Nestelberger M., Just A., Haslberger A.G. Epigenetic control of estrogen receptor expression and tumour suppressor genes is modulated by bioactive food compounds. Ann. Nutr. Metab. 2010, 57:183-189.
34. Fang J-Y., Xiao S-D Effect of trans-retinoic acid and folic acid on apoptosis in human gastric cancer cell lines MKN-45 and MKN-28. J. Gastroenterol. 1998, 33:656-661.